Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

 

Important Public Notice: ANCC Magnet Recognition Program® - Site Visit through November 4, 2022. Click here to learn more.

MENU

Fox Chase Cancer Center News

Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology
September 13, 2022

Fox Chase Cancer Center Welcomes Dr. Anthony M. Villano

PHILADELPHIA (September 13, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology.

Camille Ragin, PhD, MPH, Associate Director of Diversity, Equity, and Inclusion at Fox Chase Cancer Center
September 12, 2022

Fox Chase Cancer Center’s Camille Ragin to Co-Chair AACR Conference on Cancer Health Disparities

PHILADELPHIA (September 12, 2022)—Camille Ragin, PhD, MPH, Associate Director of Diversity, Equity, and Inclusion at Fox Chase Cancer Center, will serve as co-chair and participate in a panel discussion at this year’s 15th Annual American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.

Hayan Lee, PhD, as an assistant professor in the Cancer Signaling and Epigenetics research program
September 12, 2022

Fox Chase Cancer Center Welcomes Hayan Lee

PHILADELPHIA (September 12, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Hayan Lee, PhD, as an assistant professor in the Cancer Signaling and Epigenetics research program and the Cancer Epigenetics Institute (CEI).

Edna (Eti) Cukierman, PhD Professor Co-Leader, Cancer Signaling and Epigenetics Program
September 2, 2022

Fox Chase Researchers Discover How Pancreatic Cancer Cells Manage to Survive in Poor Nutritional Environments

PHILADELPHIA (September 2 2022)—In a recent study, researchers at Fox Chase Cancer Center demonstrated how cancer cells can survive in the body even when faced with a lack of sufficient nutrition, a finding that could be used as a potential indicator of disease status in the organs of pancreatic cancer patients.

Lu Chen, PhD, Assistant Professor in Cancer Signaling and Epigenetics
August 31, 2022

RNA Findings Could Assist in Development of New Treatments for Neurodegenerative Disorders, Cancer

PHILADELPHIA (August 31, 2022)—Researchers at Fox Chase Cancer Center co-authored a multi-institutional study that found that an RNA modification enzyme is critical for the survival of motor neurons. The scientists say the findings could help in the development of new treatments for neurological and other aging-related disorders, including cancer.

James S. Duncan, PhD, associate professor in the Cancer Signaling and Epigenetics research program at Fox Chase
August 30, 2022

Lapatinib May Boost Effectiveness of Drugs That Destroy Cancer Proteins by Blocking Resistance

PHILADELPHIA (August 30, 2022)—Researchers at Fox Chase Cancer Center have discovered that the drug efflux pump MDR1 promotes resistance to a promising new class of drugs called PROTACS—proteolysis-targeting chimeras.

Linda Fleisher, PhD, MPH, associate research professor in the Cancer Prevention and Control
August 29, 2022

National Navigation Roundtable Supplement Highlights Importance of Patient Navigation

PHILADELPHIA (August 29, 2022)—In a recently published supplement, the American Cancer Society’s National Navigation Roundtable, which is co-chaired by a Fox Chase Cancer Center researcher, provided an extensive update on the state of patient navigation and its role in oncology care.

Brian Kozera A dear member of our Fox Chase Center community
August 17, 2022

Statement of Robert Uzzo, MD, MBA, FACS, Fox Chase Cancer Center President & CEO, on the death of Brian Kozera

PHILADELPHIA (August 17, 2022)—Brian Kozera lived his life according to a very simple, yet powerful mantra: Persevere, prevail.  A dear member of our Fox Chase Cancer Center community, Brian was a cancer survivor (or cancer thriver, as he would say), fundraiser, and friend who inspired us with his resolve, his passionate spirit, and his selfless dedication to others. It is with deep sadness that I share news of his unexpected passing on August 13 in a biking accident. Brian was 44.

Pages

Connect with Fox Chase